Neumora Therapeutics (NMRA) Selling, General & Administrative (2022 - 2026)
Powered by 
Analysis
Neumora Therapeutics (NMRA) Selling, General & Administrative (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -417.00 Mn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 216.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 110.21 Mn |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 593.21 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 247.47 Mn |
| 10 | Neumora Therapeutics | 243.49 Mn | 243.49 Mn | - | 12.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.91 Mn |
| Mar 31, 2026 | 14.27 Mn |
| Dec 31, 2025 | 13.81 Mn |
| Sep 30, 2025 | 12.18 Mn |
| Jun 30, 2025 | 15.32 Mn |
| Mar 31, 2025 | 18.79 Mn |
| Dec 31, 2024 | 17.01 Mn |
| Sep 30, 2024 | 16.02 Mn |
| Jun 30, 2024 | 15.19 Mn |
| Mar 31, 2024 | 14.32 Mn |
| Dec 31, 2023 | 11.24 Mn |
| Sep 30, 2023 | 15.26 Mn |
| Jun 30, 2023 | 9.29 Mn |
| Mar 31, 2023 | 9.68 Mn |
| Dec 31, 2022 | 7.20 Mn |
| Sep 30, 2022 | 8.05 Mn |